Source: |
Type: |
Cognitive |
4039- | , | Association of vitamin B12 deficiency in a dementia cohort with hippocampal atrophy on MRI |
- | Study, | AD, | NA |
4051- | , | Long-term association of food and nutrient intakes with cognitive and functional decline: a 13-year follow-up study of elderly French women |
- | Study, | AD, | NA |
3940- | 5HT, | Role of serotonin in Alzheimer's disease: a new therapeutic target? |
- | Review, | AD, | NA |
3941- | 5HT, | dietMed, | VitB12, | FA, | VitC | Nutrition strategies that improve cognitive function |
- | Review, | AD, | NA |
- | in-vivo, | AD, | NA |
3972- | ACNs, | Recent Research on the Health Benefits of Blueberries and Their Anthocyanins |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3971- | ACNs, | Blueberry Supplementation Improves Memory in Older Adults |
- | Human, | AD, | NA |
3969- | ACNs, | Blueberry Supplementation in Midlife for Dementia Risk Reduction |
- | Human, | AD, | NA |
3968- | ACNs, | Enhanced Neuronal Activation with Blueberry Supplementation in Mild Cognitive Impairment |
- | Human, | AD, | NA |
3864- | ACNs, | Anthocyanins Potentially Contribute to Defense against Alzheimer’s Disease |
- | Review, | AD, | NA |
3865- | ACNs, | Consumption of anthocyanin-rich cherry juice for 12 weeks improves memory and cognition in older adults with mild-to-moderate dementia |
- | Human, | AD, | NA |
4163- | ACNs, | Flav, | Dietary levels of pure flavonoids improve spatial memory performance and increase hippocampal brain-derived neurotrophic factor |
- | in-vivo, | AD, | NA |
236- | AL, | Allicin: Chemistry and Biological Properties |
- | Analysis, | NA, | NA |
2558- | AL, | Allicin, an Antioxidant and Neuroprotective Agent, Ameliorates Cognitive Impairment |
- | Review, | AD, | NA |
2657- | AL, | Allicin pharmacology: Common molecular mechanisms against neuroinflammation and cardiovascular diseases |
- | Review, | CardioV, | NA | - | Review, | AD, | NA |
2660- | AL, | Allicin: A review of its important pharmacological activities |
- | Review, | AD, | NA | - | Review, | Var, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
3447- | ALA, | Redox Active α-Lipoic Acid Differentially Improves Mitochondrial Dysfunction in a Cellular Model of Alzheimer and Its Control Cells |
- | in-vitro, | AD, | SH-SY5Y |
3438- | ALA, | The Potent Antioxidant Alpha Lipoic Acid |
- | Review, | NA, | NA | - | Review, | AD, | NA |
3443- | ALA, | Molecular and Therapeutic Insights of Alpha-Lipoic Acid as a Potential Molecule for Disease Prevention |
- | Review, | Var, | NA | - | Review, | AD, | NA |
3444- | ALA, | Alpha-Lipoic Acid Nootropic Review: Benefits, Use, Dosage & Side Effects |
- | Review, | NA, | NA |
3539- | ALA, | Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential |
- | Review, | AD, | NA |
4282- | ALA, | Effect of add-on alpha lipoic acid on psychopathology in patients with treatment-resistant schizophrenia: a pilot randomized double-blind placebo-controlled trial |
- | Trial, | NA, | NA |
3272- | ALA, | Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential |
- | Review, | AD, | NA |
3271- | ALA, | Decrypting the potential role of α-lipoic acid in Alzheimer's disease |
- | Review, | AD, | NA |
3270- | ALA, | Alpha-lipoic acid as a new treatment option for Alzheimer's disease--a 48 months follow-up analysis |
- | Trial, | AD, | NA |
3269- | ALA, | Sulfur-containing therapeutics in the treatment of Alzheimer’s disease |
- | NA, | AD, | NA |
3543- | ALA, | The Effect of Lipoic Acid Therapy on Cognitive Functioning in Patients with Alzheimer's Disease |
- | Study, | AD, | NA |
3544- | ALA, | Alpha lipoic acid for dementia |
- | Review, | AD, | NA |
3545- | ALA, | Potential therapeutic effects of alpha lipoic acid in memory disorders |
- | Review, | AD, | NA |
3546- | ALA, | Cognitive and Mood Effect of Alpha-Lipoic Acid Supplementation in a Nonclinical Elder Sample: An Open-Label Pilot Study |
- | Study, | AD, | NA |
3547- | ALA, | Potential Therapeutic Effects of Lipoic Acid on Memory Deficits Related to Aging and Neurodegeneration |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3549- | ALA, | Important roles of linoleic acid and α-linolenic acid in regulating cognitive impairment and neuropsychiatric issues in metabolic-related dementia |
- | Review, | AD, | NA |
3550- | ALA, | Mitochondrial Dysfunction and Alpha-Lipoic Acid: Beneficial or Harmful in Alzheimer's Disease? |
- | Review, | AD, | NA |
3551- | ALA, | Alpha lipoic acid treatment in late middle age improves cognitive function: Proteomic analysis of the protective mechanisms in the hippocampus |
- | in-vivo, | AD, | NA |
3552- | ALA, | The dietary fatty acids α-linolenic acid (ALA) and linoleic acid (LA) selectively inhibit microglial nitric oxide production |
- | in-vitro, | AD, | BV2 |
3975- | ALC, | Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease |
- | Trial, | AD, | NA |
3974- | ALC, | Carnitine |
- | Review, | AD, | NA |
3976- | ALC, | Acetyl-L-carnitine for dementia |
- | Review, | AD, | NA |
4135- | Alum, | Aluminum Should Now Be Considered a Primary Etiological Factor in Alzheimer's Disease |
- | Review, | AD, | NA |
4124- | Alum, | The potential influence of silica present in drinking water on Alzheimer's disease and associated disorders |
- | Review, | AD, | NA |
4130- | Alum, | Silica and aluminum in drinking water and cognitive impairment in the elderly |
- | Study, | AD, | NA |
4132- | Alum, | Relation between aluminum concentrations in drinking water and Alzheimer's disease: an 8-year follow-up study |
- | Study, | AD, | NA |
4280- | Api, | Protective effects of apigenin in neurodegeneration: An update on the potential mechanisms |
- | Review, | AD, | NA | - | Review, | Park, | NA |
4279- | Api, | The Beneficial Role of Apigenin against Cognitive and Neurobehavioural Dysfunction: A Systematic Review of Preclinical Investigations |
- | Review, | NA, | NA |
3817- | Aroma, | Therapeutic potential of aromatic plant extracts in Alzheimer's disease: Comprehensive review of their underlying mechanisms |
- | Review, | AD, | NA |
3818- | Aroma, | The effect of inhaled aromatherapy on cognitive function in patients with cognitive impairment: A systematic review and meta-analysis |
- | Review, | AD, | NA |
3819- | Aroma, | Aromatherapy improves cognitive dysfunction in senescence-accelerated mouse prone 8 by reducing the level of amyloid beta and tau phosphorylation |
- | Human, | AD, | NA | - | in-vitro, | AD, | NA |
3821- | Aroma, | Neuroprotective and Anti-Aging Potentials of Essential Oils from Aromatic and Medicinal Plants |
- | Review, | AD, | NA |
3822- | Aroma, | Aromatherapy in the treatment of Alzheimer's disease: A systematic review |
- | Review, | AD, | NA |
- | Human, | AD, | NA |
3666- | ART/DHA, | Artemisinin Attenuates Amyloid-Induced Brain Inflammation and Memory Impairments by Modulating TLR4/NF-κB Signaling |
- | NA, | AD, | NA |
3667- | ART/DHA, | Artemisinin improves neurocognitive deficits associated with sepsis by activating the AMPK axis in microglia |
- | Review, | Sepsis, | NA |
3687- | Ash, | Role of Withaferin A and Its Derivatives in the Management of Alzheimer’s Disease: Recent Trends and Future Perspectives |
- | Review, | AD, | NA |
4303- | Ash, | Ashwagandha (Withania somnifera)—Current Research on the Health-Promoting Activities: A Narrative Review |
- | Review, | AD, | NA |
3675- | Ash, | Ashwagandha (Withania somnifera) Reverses β-Amyloid1-42 Induced Toxicity in Human Neuronal Cells: Implications in HIV-Associated Neurocognitive Disorders (HAND) |
3673- | Ash, | An overview on ashwagandha: a Rasayana (rejuvenator) of Ayurveda |
- | Review, | NA, | NA |
3668- | Ash, | Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver |
- | NA, | AD, | NA |
3685- | Ash, | Withania somnifera as a Potential Anxiolytic and Anti-inflammatory Candidate Against Systemic Lipopolysaccharide-Induced Neuroinflammation |
- | in-vivo, | NA, | NA |
3159- | Ash, | Neuroprotective effects of Withania somnifera in the SH-SY5Y Parkinson cell model |
- | in-vitro, | Park, | SH-SY5Y |
2605- | Ba, | BA, | Potential therapeutic effects of baicalin and baicalein |
- | Review, | Var, | NA | - | Review, | Stroke, | NA | - | Review, | IBD, | NA | - | Review, | Arthritis, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
2626- | Ba, | Molecular targets and therapeutic potential of baicalein: a review |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Stroke, | NA |
4305- | Ba, | Study on the Molecular Mechanism of Baicalin Phosphorylation of Tau Protein Content in a Cell Model of Intervention Cognitive Impairment |
- | in-vitro, | NA, | SH-SY5Y |
4300- | BBR, | Effect of berberine on cognitive function and β-amyloid precursor protein in Alzheimer’s disease models: a systematic review and meta-analysis |
- | Review, | AD, | NA |
- | in-vivo, | AD, | NA |
4298- | BBR, | Berberine mitigates cognitive decline in an Alzheimer’s Disease Mouse Model by targeting both tau hyperphosphorylation and autophagic clearance |
- | in-vivo, | AD, | NA |
3678- | BBR, | Network pharmacology study on the mechanism of berberine in Alzheimer’s disease model |
- | Review, | AD, | NA |
3680- | BBR, | Network pharmacology reveals that Berberine may function against Alzheimer’s disease via the AKT signaling pathway |
- | in-vivo, | AD, | NA |
3681- | BBR, | The efficacy and mechanism of berberine in improving aging-related cognitive dysfunction: A study based on network pharmacology |
- | in-vivo, | AD, | NA |
3682- | BBR, | Berberine Improves Cognitive Impairment by Simultaneously Impacting Cerebral Blood Flow and β-Amyloid Accumulation in an APP/tau/PS1 Mouse Model of Alzheimer’s Disease |
- | in-vitro, | AD, | NA |
2679- | BBR, | Berberine Improves Behavioral and Cognitive Deficits in a Mouse Model of Alzheimer’s Disease via Regulation of β-Amyloid Production and Endoplasmic Reticulum Stress |
- | in-vivo, | AD, | NA |
2731- | BetA, | Betulinic Acid for Glioblastoma Treatment: Reality, Challenges and Perspectives |
- | Review, | GBM, | NA | - | Review, | Park, | NA | - | Review, | AD, | NA |
- | in-vivo, | NA, | NA |
4061- | betaCar, | VitB12, | VitB6, | FA, | VitB3 | Revisiting the Role of Vitamins and Minerals in Alzheimer’s Disease |
- | Review, | AD, | NA |
4078- | betaCar, | VitC, | VitB6, | Impact of Diet on Learning, Memory and Cognition |
- | Review, | AD, | NA |
4080- | betaCar, | Vitamin A and Alzheimer's disease |
- | Review, | AD, | NA |
4082- | betaCar, | Marginal vitamin A deficiency facilitates Alzheimer's pathogenesis |
- | Study, | AD, | NA |
4083- | betaCar, | Significance of vitamin A to brain function, behavior and learning |
- | Review, | AD, | NA |
3697- | BM, | Bacopa monnieri, a Neuroprotective Lead in Alzheimer Disease: A Review on Its Properties, Mechanisms of Action, and Preclinical and Clinical Studies |
- | Review, | AD, | NA |
3690- | BM, | Neurocognitive Effect of Nootropic Drug Brahmi (Bacopa monnieri) in Alzheimer's Disease |
- | Review, | AD, | NA |
3691- | BM, | Effects of a Standardized Bacopa monnieri Extract on Cognitive Performance, Anxiety, and Depression in the Elderly: A Randomized, Double-Blind, Placebo-Controlled Trial |
- | Study, | Nor, | NA |
3692- | BM, | Brahmi (Bacopa monnieri): An ayurvedic herb against the Alzheimer's disease |
- | Review, | AD, | NA |
3693- | BM, | Bacopa monnieri prevents colchicine-induced dementia by anti-inflammatory action |
- | in-vivo, | AD, | NA |
3694- | BM, | Use of Bacopa monnieri in the Treatment of Dementia Due to Alzheimer Disease: Systematic Review of Randomized Controlled Trials |
- | Review, | AD, | NA |
3518- | Bor, | Boron Report |
- | Review, | Var, | NA | - | Review, | AD, | NA |
760- | Bor, | Therapeutic Efficacy of Boric Acid Treatment on Brain Tissue and Cognitive Functions in Rats with Experimental Alzheimer’s Disease |
- | in-vivo, | AD, | NA |
696- | Bor, | Nothing Boring About Boron |
- | Review, | Var, | NA |
2775- | Bos, | The journey of boswellic acids from synthesis to pharmacological activities |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | PSA, | NA |
2772- | Bos, | Mechanistic role of boswellic acids in Alzheimer’s disease: Emphasis on anti-inflammatory properties |
- | Review, | AD, | NA |
2768- | Bos, | Boswellic acids as promising agents for the management of brain diseases |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
4265- | CA, | Potential applications of nanomedicine for treating Parkinson's disease |
- | Review, | Park, | NA |
3791- | CA, | Caffeic Acid and Diseases—Mechanisms of Action |
- | Review, | AD, | NA |
4267- | Caff, | Caffeine‐mediated BDNF release regulates long‐term synaptic plasticity through activation of IRS2 signaling |
- | in-vivo, | NA, | NA |
4161- | Caff, | Chronic caffeine prevents changes in inhibitory avoidance memory and hippocampal BDNF immunocontent in middle-aged rats |
- | in-vivo, | AD, | NA |
3855- | CAP, | Capsaicin consumption reduces brain amyloid-beta generation and attenuates Alzheimer’s disease-type pathology and cognitive deficits in APP/PS1 mice |
- | in-vivo, | AD, | NA |
3854- | CAP, | Capsaicin consumption reduces brain amyloid-beta generation and attenuates Alzheimer’s disease-type pathology and cognitive deficits in APP/PS1 mice |
- | in-vivo, | AD, | NA |
3881- | Carno, | The Therapeutic Potential of Carnosine/Anserine Supplementation against Cognitive Decline: A Systematic Review with Meta-Analysis |
- | Review, | AD, | NA |
3880- | Carno, | EFFECT OF ANSERINE/CARNOSINE SUPPLEMENTATION ON THE PREVENTION OF ALZHEIMER'S DISEASE IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT |
- | Trial, | AD, | NA |
3879- | Carno, | Daily Carnosine and Anserine Supplementation Alters Verbal Episodic Memory and Resting State Network Connectivity in Healthy Elderly Adults |
- | Human, | AD, | NA |
3876- | Carno, | Ex, | Swimming exercise versus L-carnosine supplementation for Alzheimer’s dementia in rats: implication of circulating and hippocampal FNDC5/irisin |
- | in-vivo, | AD, | NA |
3873- | Carno, | Effects of dietary supplementation of carnosine on mitochondrial dysfunction, amyloid pathology, and cognitive deficits in 3xTg-AD mice |
- | in-vivo, | AD, | NA |
3699- | Chol, | Association of dietary cholesterol and egg intakes with the risk of incident dementia or Alzheimer disease: the Kuopio Ischaemic Heart Disease Risk Factor Study |
- | Study, | AD, | NA |
3705- | Chol, | LEC, | Effects of consumption of choline and lecithin on neurological and cardiovascular systems |
- | Review, | AD, | NA |
- | in-vivo, | NA, | NA |
2782- | CHr, | Broad-Spectrum Preclinical Antitumor Activity of Chrysin: Current Trends and Future Perspectives |
- | Review, | Var, | NA | - | Review, | Stroke, | NA | - | Review, | Park, | NA |
1567- | Cin, | Cinnamon: Mystic powers of a minute ingredient |
- | Review, | Var, | NA |
3889- | Cin, | Orally administrated cinnamon extract reduces β-amyloid oligomerization and corrects cognitive impairment in Alzheimer's disease animal models |
- | in-vivo, | AD, | NA |
3888- | Cin, | Cinnamon, a promising prospect towards Alzheimer's disease |
- | NA, | AD, | NA |
4258- | CoQ10, | Neuroprotective effects of coenzyme Q10-loaded exosomes obtained from adipose-derived stem cells in a rat model of Alzheimer's disease |
- | in-vivo, | AD, | NA |
3993- | CoQ10, | Coenzyme Q10 Decreases Amyloid Pathology and Improves Behavior in a Transgenic Mouse Model of Alzheimer’s Disease |
- | Review, | Park, | NA | - | Review, | AD, | NA |
3997- | CoQ10, | Coenzyme Q and Its Role in the Dietary Therapy against Aging |
- | Review, | AD, | NA |
3625- | Croc, | Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial |
- | Trial, | AD, | NA |
3626- | Croc, | Comparing the efficacy and safety of Crocus sativus L. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial |
- | Trial, | AD, | NA |
3627- | Croc, | The effects of Crocus sativus (saffron) and its constituents on nervous system: A review |
- | Review, | AD, | NA | - | Review, | Stroke, | NA |
3628- | Croc, | VitE, | CUR, | Vitamin E, Turmeric and Saffron in Treatment of Alzheimer’s Disease |
- | Review, | AD, | NA |
3631- | Croc, | Investigation of the neuroprotective effects of crocin via antioxidant activities in HT22 cells and in mice with Alzheimer's disease |
- | in-vitro, | AD, | HT22 | - | in-vivo, | AD, | NA |
3634- | Croc, | A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease |
- | Trial, | AD, | NA |
3635- | Croc, | A Review of Potential Efficacy of Saffron (Crocus sativus L.) in Cognitive Dysfunction and Seizures |
- | Review, | NA, | NA |
3637- | Croc, | Investigation of the neuroprotective action of saffron (Crocus sativus L.) in aluminum-exposed adult mice through behavioral and neurobiochemical assessment |
- | NA, | AD, | NA |
3624- | Croc, | Crocus Sativus L. (Saffron) in Alzheimer's Disease Treatment: Bioactive Effects on Cognitive Impairment |
- | Review, | AD, | NA |
3832- | Croc, | Traditional Chinese Medicine: Role in Reducing β-Amyloid, Apoptosis, Autophagy, Neuroinflammation, Oxidative Stress, and Mitochondrial Dysfunction of Alzheimer’s Disease |
- | Review, | AD, | NA |
2818- | CUR, | Novel Insight to Neuroprotective Potential of Curcumin: A Mechanistic Review of Possible Involvement of Mitochondrial Biogenesis and PI3/Akt/ GSK3 or PI3/Akt/CREB/BDNF Signaling Pathways |
- | Review, | AD, | NA |
2816- | CUR, | NEUROPROTECTIVE EFFECTS OF CURCUMIN |
- | Review, | AD, | NA | - | Review, | Park, | NA |
2688- | CUR, | Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs |
- | Review, | Var, | NA | - | Review, | AD, | NA |
3797- | CUR, | Curcumin reverses cognitive deficits through promoting neurogenesis and synapse plasticity via the upregulation of PSD95 and BDNF in mice |
- | in-vitro, | NA, | NA |
3748- | CUR, | RES, | Hup, | Riv, | Gala | Natural acetylcholinesterase inhibitors: A multi-targeted therapeutic potential in Alzheimer's disease |
- | Review, | AD, | NA |
3753- | CUR, | Gala, | A Novel Galantamine–Curcumin Hybrid Inhibits Butyrylcholinesterase: A Molecular Dynamics Study |
- | Study, | AD, | NA |
3574- | CUR, | The effect of curcumin (turmeric) on Alzheimer's disease: An overview |
- | Review, | AD, | NA |
3576- | CUR, | Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer's Disease |
- | Review, | AD, | NA |
3577- | CUR, | Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study |
- | Trial, | AD, | NA |
3581- | CUR, | Curcumin Attenuated Neurotoxicity in Sporadic Animal Model of Alzheimer's Disease |
- | NA, | AD, | NA |
3590- | CUR, | The Holy Grail of Curcumin and its Efficacy in Various Diseases: Is Bioavailability Truly a Big Concern? |
- | Review, | Var, | NA | - | Review, | AD, | NA |
3588- | CUR, | The effect of curcumin on cognition in Alzheimer’s disease and healthy aging: A systematic review of pre-clinical and clinical studies |
- | Review, | AD, | NA |
4177- | DHA, | Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats |
- | in-vivo, | NA, | NA |
4178- | DHA, | The salutary effects of DHA dietary supplementation on cognition, neuroplasticity, and membrane homeostasis after brain trauma |
- | in-vivo, | NA, | NA |
2272- | dietMet, | Methionine restriction - Association with redox homeostasis and implications on aging and diseases |
- | Review, | Nor, | NA |
3709- | dietSTF, | Intermittent Fasting Protects against Alzheimer’s Disease Possible through Restoring Aquaporin-4 Polarity |
- | in-vitro, | AD, | NA |
3708- | dietSTF, | Fasting as a Therapy in Neurological Disease |
4254- | EA, | Chronic administration of ellagic acid improved the cognition in middle-aged overweight men |
- | Human, | Obesity, | NA |
- | Human, | MS, | NA | - | NA, | IBD, | NA |
3593- | EGCG, | Epigallocatechin Gallate (EGCG) |
- | Review, | AD, | NA |
3232- | EGCG, | (−)-Epigallocatechin-3-gallate attenuates cognitive deterioration in Alzheimer׳s disease model mice by upregulating neprilysin expression |
- | in-vivo, | AD, | NA |
3237- | EGCG, | (-)-Epigallocatechin-3-gallate attenuates cognitive deterioration in Alzheimer's disease model mice by upregulating neprilysin expression |
- | in-vivo, | AD, | NA |
2153- | Ex, | The Impact of Exercise on Cancer Mortality, Recurrence, and Treatment-Related Adverse Effects |
- | Review, | Var, | NA |
3985- | Ex, | The combined effect of physical activity and fruit and vegetable intake on decreasing cognitive decline in older Taiwanese adults |
- | Study, | AD, | NA |
4142- | Ex, | Mechanisms of the Beneficial Effects of Exercise on Brain-Derived Neurotrophic Factor Expression in Alzheimer’s Disease |
- | Review, | AD, | NA |
4137- | Ex, | The impact of exercise on patients with dementia |
- | Trial, | AD, | NA |
4138- | Ex, | Relationship Between Exercise and Alzheimer’s Disease: A Narrative Literature Review |
- | Review, | AD, | NA |
4139- | Ex, | Impact of physical exercise on the regulation of brain-derived neurotrophic factor in people with neurodegenerative diseases |
- | Review, | AD, | NA |
4140- | Ex, | Experimental and clinical evidence of physical exercise on BDNF and cognitive function: A comprehensive review from molecular basis to therapy |
- | Review, | AD, | NA |
4144- | Ex, | Exploring the impact of exercise-induced BDNF on neuroplasticity in neurodegenerative and neuropsychiatric conditions |
- | Review, | AD, | NA |
4174- | Ex, | Exercise-Mediated Neurogenesis in the Hippocampus via BDNF |
- | Review, | NA, | NA |
3782- | FA, | Ferulic acid ameliorates bisphenol A (BPA)-induced Alzheimer’s disease-like pathology through Akt-ERK crosstalk pathway in male rats |
- | in-vivo, | AD, | NA |
3712- | FA, | Ferulic Acid: A Hope for Alzheimer’s Disease Therapy from Plants |
- | Review, | AD, | NA |
3714- | FA, | Recent Advances in the Neuroprotective Properties of Ferulic Acid in Alzheimer's Disease: A Narrative Review |
- | Review, | AD, | NA |
3715- | FA, | CUR, | PS, | The Additive Effects of Low Dose Intake of Ferulic Acid, Phosphatidylserine and Curcumin, Not Alone, Improve Cognitive Function in APPswe/PS1dE9 Transgenic Mice |
- | in-vivo, | AD, | NA |
4059- | FA, | Dietary B Vitamins and a 10-Year Risk of Dementia in Older Persons |
- | Study, | AD, | NA |
4075- | FA, | Folic acid, ageing, depression, and dementia |
- | Review, | AD, | NA |
4044- | FA, | Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial |
- | Trial, | AD, | NA |
4074- | FA, | VitB12, | Associations between Alzheimer's disease and blood homocysteine, vitamin B12, and folate: a case-control study |
- | Trial, | AD, | NA |
4073- | FA, | The importance of folic acid deficiency in the pathogenesis of vascular, mixed and Alzheimer's disease dementia |
- | Study, | AD, | NA |
4072- | FA, | Folic acid with or without vitamin B12 for cognition and dementia |
- | Review, | AD, | NA |
4071- | FA, | Folate and Alzheimer: when time matters |
- | Review, | AD, | NA |
4070- | FA, | Folic Acid Supplementation Mitigates Alzheimer's Disease by Reducing Inflammation: A Randomized Controlled Trial |
- | Trial, | AD, | NA |
4064- | FA, | VitB6, | VitB12, | High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial |
- | Trial, | AD, | NA |
2861- | FIS, | The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: Focus on the role of oxidative stress |
- | Review, | Nor, | NA | - | Review, | Stroke, | NA | - | Review, | Park, | NA |
4063- | Flav, | VitB12, | VitB6, | Homocysteine and Dementia: An International Consensus Statement |
- | Review, | AD, | NA |
4060- | Flav, | Vitamin Supplementation and Dementia: A Systematic Review |
- | Review, | AD, | NA |
4107- | FLS, | Ex, | Combined effects of aerobic exercise and 40-Hz light flicker exposure on early cognitive impairments in Alzheimer's disease of 3×Tg mice |
- | in-vivo, | AD, | NA |
4121- | FLS, | Sensory-Evoked 40-Hz Gamma Oscillation Improves Sleep and Daily Living Activities in Alzheimer’s Disease Patients |
- | Trial, | AD, | NA |
4016- | FulvicA, | Shilajit: A Natural Phytocomplex with Potential Procognitive Activity |
- | Review, | AD, | NA |
4020- | FulvicA, | Natural products as a rich source of tau-targeting drugs for Alzheimer’s disease |
- | in-vitro, | AD, | NA |
4017- | FulvicA, | Fulvic acid inhibits aggregation and promotes disassembly of tau fibrils associated with Alzheimer's disease |
- | NA, | AD, | NA |
4248- | Gala, | Meta-analysis of randomized controlled trials of galantamine in schizophrenia: significant cognitive enhancement |
- | Review, | NA, | NA |
3723- | Gb, | Can We Use Ginkgo biloba Extract to Treat Alzheimer’s Disease? Lessons from Preclinical and Clinical Studies |
- | Review, | AD, | NA |
3829- | Gins, | Traditional Chinese Medicine: Role in Reducing β-Amyloid, Apoptosis, Autophagy, Neuroinflammation, Oxidative Stress, and Mitochondrial Dysfunction of Alzheimer’s Disease |
- | Review, | AD, | NA |
4302- | Gins, | Panax ginseng: A modulator of amyloid, tau pathology, and cognitive function in Alzheimer's disease |
- | Review, | AD, | NA |
3999- | Gins, | Panax ginseng enhances cognitive performance in Alzheimer disease |
- | Trial, | NA, | NA |
4000- | Gins, | Heat-processed ginseng enhances the cognitive function in patients with moderately severe Alzheimer's disease |
- | Human, | AD, | NA |
4001- | Gins, | An open-label trial of Korean red ginseng as an adjuvant treatment for cognitive impairment in patients with Alzheimer's disease |
- | Human, | AD, | NA |
4002- | Gins, | Improvement of cognitive deficit in Alzheimer's disease patients by long term treatment with korean red ginseng |
- | Trial, | AD, | NA |
2521- | H2, | Oxyhydrogen Gas: A Promising Therapeutic Approach for Lung, Breast and Colorectal Cancer |
- | Review, | CRC, | NA | - | Review, | Lung, | NA | - | Review, | BC, | NA |
3762- | H2, | Effects of Molecular Hydrogen Assessed by an Animal Model and a Randomized Clinical Study on Mild Cognitive Impairment |
- | in-vivo, | AD, | NA |
3775- | H2, | Molecular hydrogen therapy for neurological diseases: a review of current evidence |
- | Review, | AD, | NA | - | Review, | Stroke, | NA |
3774- | H2, | The role of hydrogen in Alzheimer’s disease |
- | Review, | AD, | NA |
3772- | H2, | Therapeutic potential of hydrogen-rich water in zebrafish model of Alzheimer’s disease: targeting oxidative stress, inflammation, and the gut-brain axis |
- | in-vivo, | AD, | NA |
3770- | H2, | Role of Molecular Hydrogen in Ageing and Ageing-Related Diseases |
- | Review, | AD, | NA | - | Review, | Park, | NA |
- | Review, | AD, | NA | - | Review, | Stroke, | NA |
3761- | H2, | Therapeutic Inhalation of Hydrogen Gas for Alzheimer's Disease Patients and Subsequent Long-Term Follow-Up as a Disease-Modifying Treatment: An Open Label Pilot Study |
- | Human, | AD, | NA |
3763- | H2, | Long-Term Inhalation of Hydrogen Gas for Patients with Advanced Alzheimer's Disease: A Case Report Showing Improvement in Fecal Incontinence |
- | Case Report, | AD, | NA |
3764- | H2, | Therapeutic Effects of Hydrogen Gas Inhalation on Trimethyltin-Induced Neurotoxicity and Cognitive Impairment in the C57BL/6 Mice Model |
- | in-vivo, | AD, | NA |
3765- | H2, | Therapeutic Inhalation of Hydrogen Gas for Alzheimer’s Disease Patients and Subsequent Long-Term Follow-Up as a Disease-Modifying Treatment: An Open Label Pilot Study |
- | Study, | AD, | NA |
3766- | H2, | The role of hydrogen in Alzheimer′s disease |
- | Review, | AD, | NA |
3767- | H2, | The role of hydrogen therapy in Alzheimer's disease management: Insights into mechanisms, administration routes, and future challenges |
- | Review, | AD, | NA |
3768- | H2, | Effects of Hydrogen Gas Inhalation on Community-Dwelling Adults of Various Ages: A Single-Arm, Open-Label, Prospective Clinical Trial |
- | Trial, | AD, | NA |
- | in-vivo, | Sepsis, | NA |
4234- | H2, | Hydrogen gas alleviates sepsis-induced neuroinflammation and cognitive impairment through regulation of DNMT1 and DNMT3a-mediated BDNF promoter IV methylation in mice |
- | in-vivo, | Sepsis, | NA |
4308- | H2, | A biomimetic upconversion nanoreactors for near-infrared driven H2 release to inhibit tauopathy in Alzheimer's disease therapy |
- | in-vivo, | AD, | NA |
4307- | H2, | Hydrogen Gas Attenuates Toxic Metabolites and Oxidative Stress-Mediated Signaling to Inhibit Neurodegeneration and Enhance Memory in Alzheimer’s Disease Models |
- | in-vivo, | AD, | NA |
4241- | HNK, | Effects of Honokiol on Neurological Injury and Cognitive Function in Mice with Intracerebral Hemorrhage by Regulating BDNF-TrkB-CREB Signaling Pathway |
- | in-vivo, | Stroke, | NA |
2869- | HNK, | Nature's neuroprotector: Honokiol and its promise for Alzheimer's and Parkinson's |
- | Review, | AD, | NA | - | Review, | Park, | NA |
2872- | HNK, | Honokiol alleviated neurodegeneration by reducing oxidative stress and improving mitochondrial function in mutant SOD1 cellular and mouse models of amyotrophic lateral sclerosis |
- | in-vivo, | ALS, | NA | - | NA, | Stroke, | NA | - | NA, | AD, | NA | - | NA, | Park, | NA |
4213- | Hup, | Huperzine A-Liposomes Efficiently Improve Neural Injury in the Hippocampus of Mice with Chronic Intermittent Hypoxia |
- | in-vivo, | NA, | NA |
4209- | Hup, | Huperzine A, reduces brain iron overload and alleviates cognitive deficit in mice exposed to chronic intermittent hypoxia |
- | in-vivo, | NA, | NA |
4211- | Hup, | Huperzine A ameliorates obesity-related cognitive performance impairments involving neuronal insulin signaling pathway in mice |
- | in-vitro, | NA, | NA |
3804- | Hup, | Huperzine A for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials |
- | Review, | AD, | NA |
3803- | Hup, | Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer’s Disease |
- | Review, | AD, | NA |
3800- | Hup, | Role of huperzine a in the treatment of Alzheimer's disease |
- | Review, | AD, | NA |
4007- | K+, | The increased potassium intake improves cognitive performance and attenuates histopathological markers in a model of Alzheimer's disease |
- | in-vivo, | AD, | NA |
4013- | K+, | Apamin Improves Prefrontal Nicotinic Impairment in Mouse Model of Alzheimer's Disease |
- | in-vitro, | AD, | NA |
3706- | LEC, | Lecithin for dementia and cognitive impairment |
- | Review, | AD, | NA |
4292- | LT, | Luteolin for neurodegenerative diseases: a review |
- | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | MS, | NA | - | Review, | Stroke, | NA |
4293- | LT, | Regulatory Role of NF-κB on HDAC2 and Tau Hyperphosphorylation in Diabetic Encephalopathy and the Therapeutic Potential of Luteolin |
- | in-vivo, | Diabetic, | NA |
4194- | Lut, | Zeax, | Effect of macular pigment carotenoids on cognitive functions: A systematic review |
- | Review, | NA, | NA |
4195- | Lut, | Zeax, | Low Xanthophylls, Retinol, Lycopene, and Tocopherols in Grey and White Matter of Brains with Alzheimer’s Disease |
- | Human, | AD, | NA |
4193- | Lut, | Zeax, | Effects of a Lutein and Zeaxanthin Intervention on Cognitive Function: A Randomized, Double-Masked, Placebo-Controlled Trial of Younger Healthy Adults |
- | Trial, | NA, | NA |
4192- | Lut, | Zeax, | Lutein and Zeaxanthin Supplementation Improves Dynamic Visual and Cognitive Performance in Children: A Randomized, Double-Blind, Parallel, Placebo-Controlled Study |
- | Trial, | NA, | NA |
3977- | Lut, | Zeax, | Dietary carotenoids related to risk of incident Alzheimer dementia (AD) and brain AD neuropathology: a community-based cohort of older adults |
- | Trial, | AD, | NA |
3983- | Lut, | Zeax, | The impact of supplemental macular carotenoids in Alzheimer's disease: a randomized clinical trial |
- | Trial, | AD, | NA |
3981- | Lut, | Zeax, | VitE, | Omega-3 fatty acid, carotenoid and vitamin E supplementation improves working memory in older adults: A randomised clinical trial |
- | Trial, | AD, | NA |
3978- | Lut, | Zeax, | Effects of Lutein/Zeaxanthin Supplementation on the Cognitive Function of Community Dwelling Older Adults: A Randomized, Double-Masked, Placebo-Controlled Trial |
- | Trial, | AD, | NA |
3268- | Lyco, | Lycopene as a Natural Antioxidant Used to Prevent Human Health Disorders |
- | Review, | AD, | NA |
4230- | Lyco, | Supplementation of lycopene attenuates oxidative stress induced neuroinflammation and cognitive impairment via Nrf2/NF-κB transcriptional pathway |
- | in-vivo, | AD, | NA |
4229- | Lyco, | Implicating the role of lycopene in restoration of mitochondrial enzymes and BDNF levels in β-amyloid induced Alzheimer׳s disease |
- | in-vivo, | AD, | NA |
4228- | Lyco, | A review for the pharmacological effect of lycopene in central nervous system disorders |
- | Review, | AD, | NA | - | Review, | Park, | NA |
2540- | M-Blu, | Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots |
- | Review, | Var, | NA | - | Review, | AD, | NA |
3902- | MCT, | Effects of Caprylic Triglyceride on Cognitive Performance and Cerebral Glucose Metabolism in Mild Alzheimer’s Disease: A Single-Case Observation |
- | Case Report, | AD, | NA |
3905- | MCT, | Medium Chain Triglycerides induce mild ketosis and may improve cognition in Alzheimer's disease. A systematic review and meta-analysis of human studies |
- | Review, | AD, | NA |
3904- | MCT, | Retrospective cohort study of the efficacy of caprylic triglyceride in patients with mild-to-moderate alzheimer’s disease |
- | Human, | AD, | NA |
3903- | MCT, | Retrospective case studies of the efficacy of caprylic triglyceride in mild-to-moderate Alzheimer’s disease |
- | Case Report, | AD, | NA |
3901- | MCT, | Potential of Capric Acid in Neurological Disorders: An Overview |
- | Review, | AD, | NA |
3899- | MCT, | COCONUT OIL: NON-ALTERNATIVE DRUG TREATMENT AGAINST ALZHEIMER´S DISEASE |
- | Human, | AD, | NA |
3898- | MCT, | Potential of coconut oil and medium chain triglycerides in the prevention and treatment of Alzheimer's disease |
- | Review, | AD, | NA |
3896- | MCT, | Improvement of Main Cognitive Functions in Patients with Alzheimer's Disease after Treatment with Coconut Oil Enriched Mediterranean Diet: A Pilot Study |
- | Trial, | AD, | NA |
3895- | MCT, | How does coconut oil affect cognitive performance in alzheimer patients? |
- | Human, | AD, | NA |
3728- | MF, | Long-term exposure to ELF-MF ameliorates cognitive deficits and attenuates tau hyperphosphorylation in 3xTg AD mice |
- | in-vivo, | AD, | NA |
3727- | MF, | RKIP-Mediated NF-κB Signaling is involved in ELF-MF-mediated improvement in AD rat |
- | in-vivo, | AD, | NA |
3726- | MF, | Spatial memory recovery in Alzheimer's rat model by electromagnetic field exposure |
- | in-vivo, | AD, | NA |
3725- | MF, | Short-term effects of extremely low frequency electromagnetic fields exposure on Alzheimer's disease in rats |
- | in-vivo, | AD, | NA |
3746- | MF, | Low-Frequency Pulsed Electromagnetic Field Is Able to Modulate miRNAs in an Experimental Cell Model of Alzheimer's Disease |
- | in-vitro, | AD, | NA |
3744- | MF, | Cognitive improvement via a modulated rhythmic pulsed magnetic field in D-galactose-induced accelerated aging mice |
- | in-vivo, | AD, | NA |
3739- | MF, | Early intervention using long-term rhythmic pulsed magnetic stimulation alleviates cognitive decline in a 5xFAD mouse model of Alzheimer's disease |
- | in-vivo, | AD, | NA |
3740- | MF, | Gamma rhythm low field magnetic stimulation alleviates neuropathologic changes and rescues memory and cognitive impairments in a mouse model of Alzheimer's disease |
- | in-vivo, | AD, | NA |
3742- | MF, | The role of magnetic fields in neurodegenerative diseases |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3734- | MF, | Extremely low frequency electromagnetic fields promote cognitive function and hippocampal neurogenesis of rats with cerebral ischemia |
- | in-vivo, | AD, | NA |
4106- | MF, | Cognitive Decline: Current Intervention Strategies and Integrative Therapeutic Approaches for Alzheimer's Disease |
- | Review, | AD, | NA |
4098- | MF, | Extremely low frequency electromagnetic field (ELF-EMF) reduces oxidative stress and improves functional and psychological status in ischemic stroke patients |
- | Trial, | Stroke, | NA |
4101- | MF, | Benign Effect of Extremely Low-Frequency Electromagnetic Field on Brain Plasticity Assessed by Nitric Oxide Metabolism during Poststroke Rehabilitation |
- | Human, | Stroke, | NA |
4119- | MF, | Therapeutic potential and mechanisms of repetitive transcranial magnetic stimulation in Alzheimer’s disease: a literature review |
- | Review, | AD, | NA |
4118- | MF, | Effects of transcranial magnetic stimulation on neurobiological changes in Alzheimer's disease |
- | Review, | AD, | NA |
204- | MFrot, | MF, | Rotating magnetic field improved cognitive and memory impairments in a sporadic ad model of mice by regulating microglial polarization |
- | in-vivo, | AD, | NA |
185- | MFrot, | MF, | Case Report: End-Stage Recurrent Glioblastoma Treated With a New Noninvasive Non-Contact Oncomagnetic Device |
- | Human, | GBM, | NA |
212- | MFrot, | MF, | Rotating magnetic field inhibits Aβ protein aggregation and alleviates cognitive impairment in Alzheimer’s disease mice |
- | in-vivo, | AD, | SH-SY5Y |
3567- | MFrot, | MF, | The Effect of Extremely Low-Frequency Magnetic Field on Stroke Patients: A Systematic Review |
- | Review, | Stroke, | NA |
3745- | MFrot, | MF, | The neurobiological foundation of effective repetitive transcranial magnetic brain stimulation in Alzheimer's disease |
- | Review, | AD, | NA |
3488- | MFrot, | MF, | Rotating magnetic field improves cognitive and memory impairments in APP/PS1 mice by activating autophagy and inhibiting the PI3K/AKT/mTOR signaling pathway |
- | in-vivo, | AD, | NA |
3489- | MFrot, | MF, | Rotating magnetic field inhibits Aβ protein aggregation and alleviates cognitive impairment in Alzheimer's disease mice. |
- | in-vivo, | AD, | NA |
3840- | Moringa, | Moringa oleifera Mitigates Memory Impairment and Neurodegeneration in Animal Model of Age-Related Dementia |
- | in-vivo, | AD, | NA |
3834- | Moringa, | Moringa Oleifera Alleviates Homocysteine-Induced Alzheimer's Disease-Like Pathology and Cognitive Impairments |
- | in-vivo, | AD, | NA |
3835- | Moringa, | Moringa Oleifera Alleviates Aβ Burden and Improves Synaptic Plasticity and Cognitive Impairments in APP/PS1 Mice |
- | in-vivo, | AD, | NA |
3813- | mushLions, | Erinacine A-enriched Hericium erinaceus mycelium ameliorates Alzheimer's disease-related pathologies in APPswe/PS1dE9 transgenic mice |
- | in-vitro, | AD, | NA |
3815- | mushLions, | Neurohealth Properties of Hericium erinaceus Mycelia Enriched with Erinacines |
- | Review, | Stroke, | NA | - | Review, | Park, | NA | - | Review, | AD, | NA |
3814- | mushLions, | Lion's Mane (Hericium erinaceus) Exerts Anxiolytic Effects in the rTg4510 Tau Mouse Model |
- | in-vitro, | AD, | NA |
- | in-vitro, | AD, | NA |
3809- | mushLions, | The Monkey Head Mushroom and Memory Enhancement in Alzheimer's Disease |
- | Review, | NA, | NA |
2484- | mushLions, | Neurotrophic and Neuroprotective Effects of Hericium erinaceus |
- | Review, | Stroke, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
4036- | NAD, | VitB3, | NAD+ supplementation normalizes key Alzheimer’s features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency |
- | in-vivo, | AD, | NA |
2933- | NAD, | Nicotinamide mononucleotide (NMN) as an anti-aging health product – Promises and safety concerns |
- | Review, | Nor, | NA | - | NA, | AD, | NA | - | NA, | Diabetic, | NA | - | NA, | Stroke, | NA | - | NA, | LiverDam, | NA | - | NA, | Park, | NA |
4224- | NarG, | The Effect of Naringin on Cognitive-Behavioral Functions, CREB/BDNF Signaling, Cholinergic Activity, and Neuronal Density in the Hippocampus of an MSG-Induced Obesity Rat Model |
- | in-vivo, | Obesity, | NA | - | NA, | AD, | NA |
2032- | PB, | Phenylbutyric acid reduces amyloid plaques and rescues cognitive behavior in AD transgenic mice |
- | in-vivo, | AD, | NA |
4218- | PBG, | The Neuroprotective Effects of Brazilian Green Propolis on Neurodegenerative Damage in Human Neuronal SH-SY5Y Cells |
- | in-vitro, | Nor, | SH-SY5Y | - | in-vitro, | AD, | NA |
3249- | PBG, | Can Propolis Be a Useful Adjuvant in Brain and Neurological Disorders and Injuries? A Systematic Scoping Review of the Latest Experimental Evidence |
- | Review, | Var, | NA |
3595- | PI, | Black pepper and health claims: a comprehensive treatise |
- | Review, | Var, | NA | - | Review, | AD, | NA |
3598- | PI, | Piperine attenuates cognitive impairment in an experimental mouse model of sporadic Alzheimer's disease |
- | in-vivo, | AD, | NA |
3587- | PI, | Piperine: A review of its biological effects |
- | Review, | Park, | NA | - | Review, | AD, | NA |
2963- | PL, | Piperlongumine activates Sirtuin1 and improves cognitive function in a murine model of Alzheimer’s disease |
- | in-vitro, | AD, | HEK293 |
3917- | PS, | Phosphatidylserine, inflammation, and central nervous system diseases |
- | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
3906- | PS, | Effects of phosphatidylserine in Alzheimer's disease |
- | Study, | AD, | NA |
3907- | PS, | Long-term effects of phosphatidylserine, pyritinol, and cognitive training in Alzheimer's disease. A neuropsychological, EEG, and PET investigation |
- | Study, | AD, | NA |
3908- | PS, | The effect of phosphatidylserine-containing omega-3 fatty acids on memory abilities in subjects with subjective memory complaints: a pilot study |
- | Human, | AD, | NA |
3909- | PS, | Double-blind study with phosphatidylserine (PS) in parkinsonian patients with senile dementia of Alzheimer's type (SDAT) |
- | Study, | AD, | NA |
- | Human, | AD, | NA |
3912- | PS, | Cognitive decline in the elderly: a double-blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration |
- | Study, | AD, | NA |
3913- | PS, | An open trial of plant-source derived phosphatydilserine for treatment of age-related cognitive decline |
- | Human, | AD, | NA |
3914- | PS, | Soybean-Derived Phosphatidylserine Improves Memory Function of the Elderly Japanese Subjects with Memory Complaints |
- | Trial, | AD, | NA |
- | Trial, | AD, | NA |
3916- | PS, | The effect of soybean-derived phosphatidylserine on cognitive performance in elderly with subjective memory complaints: a pilot study |
- | Human, | AD, | NA |
3923- | PTS, | Pterostilbene Supplement Benefits: Longevity Miracle or Hoax |
- | Review, | AD, | NA |
3920- | PTS, | Resveratrol, pterostilbene, and dementia |
- | Review, | AD, | NA |
3919- | PTS, | Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer's disease |
- | in-vivo, | AD, | NA |
3347- | QC, | Recent Advances in Potential Health Benefits of Quercetin |
- | Review, | Var, | NA | - | Review, | AD, | NA |
3367- | QC, | Targeting Nrf2 signaling pathway by quercetin in the prevention and treatment of neurological disorders: An overview and update on new developments |
- | Review, | Stroke, | NA | - | Review, | AD, | NA |
3336- | QC, | Neuroprotective Effects of Quercetin in Alzheimer’s Disease |
- | Review, | AD, | NA |
4297- | QC, | Quercetin attenuates tau hyperphosphorylation and improves cognitive disorder via suppression of ER stress in a manner dependent on AMPK pathway |
- | in-vitro, | AD, | SH-SY5Y |
3601- | QC, | Overviews of Biological Importance of Quercetin: A Bioactive Flavonoid |
- | Review, | Var, | NA | - | Review, | AD, | NA |
3602- | QC, | The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice |
- | in-vivo, | AD, | NA |
3604- | QC, | Quercetin enrich diet during the early-middle not middle-late stage of alzheimer’s disease ameliorates cognitive dysfunction |
- | in-vivo, | AD, | NA |
3607- | QC, | Mechanisms of Neuroprotection by Quercetin: Counteracting Oxidative Stress and More |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3100- | RES, | Neuroprotective effects of resveratrol in Alzheimer disease pathology |
- | Review, | AD, | NA |
3099- | RES, | Resveratrol and cognitive decline: a clinician perspective |
- | Review, | Nor, | NA | - | NA, | AD, | NA |
3612- | RES, | Resveratrol in Alzheimer's disease: a review of pathophysiology and therapeutic potential |
- | Review, | AD, | NA |
4285- | RES, | Resveratrol Rescues Tau-Induced Cognitive Deficits and Neuropathology in a Mouse Model of Tauopathy |
- | in-vivo, | AD, | NA |
3730- | RF, | Transcranial electromagnetic treatment against Alzheimer's disease: why it has the potential to trump Alzheimer's disease drug development |
- | Review, | AD, | NA |
3729- | RF, | Review of the Evidence that Transcranial Electromagnetic Treatment will be a Safe and Effective Therapeutic Against Alzheimer's Disease |
- | in-vivo, | AD, | NA |
3731- | RF, | Electromagnetic field treatment protects against and reverses cognitive impairment in Alzheimer's disease mice |
- | in-vivo, | AD, | NA |
3732- | RF, | Electromagnetic treatment to old Alzheimer's mice reverses β-amyloid deposition, modifies cerebral blood flow, and provides selected cognitive benefit |
- | in-vivo, | AD, | NA |
- | in-vivo, | AD, | NA |
3736- | RF, | Long-term electromagnetic pulse exposure induces Abeta deposition and cognitive dysfunction through oxidative stress and overexpression of APP and BACE1 |
- | in-vivo, | AD, | NA |
3738- | RF, | Electromagnetic Field Stimulation Therapy for Alzheimer's Disease |
- | Review, | AD, | NA |
3490- | RF, | Multidimensional insights into the repeated electromagnetic field stimulation and biosystems interaction in aging and age-related diseases |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3461- | RF, | Electromagnetic Field Stimulation Therapy for Alzheimer’s Disease |
- | Review, | AD, | NA |
3616- | RosA, | Therapeutic effects of rosemary (Rosmarinus officinalis L.) and its active constituents on nervous system disorders |
- | Review, | AD, | NA |
3617- | RosA, | Aroma, | Effect of aromatherapy on patients with Alzheimer's disease |
- | in-vivo, | AD, | NA |
3621- | RosA, | Short-Term Study on the Effects of Rosemary on Cognitive Function in an Elderly Population |
- | Trial, | AD, | NA |
3020- | RosA, | Protective Effect of Rosmarinic Acid on Endotoxin-Induced Neuronal Damage Through Modulating GRP78/PERK/MANF Pathway |
- | in-vivo, | Nor, | NA | - | in-vitro, | NA, | SH-SY5Y |
3022- | RosA, | Rosmarinic acid against cognitive impairment via RACK1/HIF-1α regulated microglial polarization in sepsis-surviving mice |
- | in-vitro, | Sepsis, | NA |
3932- | RT, | Rutin as a Natural Therapy for Alzheimer's Disease: Insights into its Mechanisms of Action |
- | Review, | AD, | NA |
3933- | RT, | The Pharmacological Potential of Rutin |
- | Review, | AD, | NA | - | Review, | Stroke, | NA | - | Review, | Arthritis, | NA |
3934- | RT, | Rutin: A Potential Therapeutic Agent for Alzheimer Disease |
- | Review, | AD, | NA |
3935- | RT, | Sodium rutin ameliorates Alzheimer's disease-like pathology by enhancing microglial amyloid-β clearance |
- | in-vivo, | AD, | NA |
3937- | RT, | Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer’s disease |
- | in-vivo, | AD, | NA |
4217- | Sage, | RosA, | Aroma, | Neuroprotective Potential of Aromatic Herbs: Rosemary, Sage, and Lavender |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3643- | Sage, | Effects of cholinesterase inhibiting sage (Salvia officinalis) on mood, anxiety and performance on a psychological stressor battery |
- | Human, | Nor, | NA |
3644- | Sage, | Positive modulation of mood and cognitive performance following administration of acute doses of Salvia lavandulaefolia essential oil to healthy young volunteers |
- | Human, | AD, | NA |
3642- | Sage, | Chronic Supplementation with a Mix of Salvia officinalis and Salvia lavandulaefolia Improves Morris Water Maze Learning in Normal Adult C57Bl/6J Mice |
- | in-vivo, | AD, | NA |
3641- | Sage, | Systematic Review of Clinical Trials Assessing Pharmacological Properties of Salvia Species on Memory, Cognitive Impairment and Alzheimer's Disease |
- | Review, | AD, | NA |
3639- | Sage, | Pharmacological properties of Salvia officinalis and its components |
- | Review, | AD, | NA | - | Review, | Var, | NA |
3638- | Sage, | Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial |
- | Trial, | AD, | NA |
3939- | SAMe, | VitB12, | ALC, | Efficacy of a Vitamin/Nutriceutical Formulation for Moderate-stage to Later-stage Alzheimer's disease: A Placebo-controlled Pilot Study |
- | Trial, | NA, | NA |
4085- | Se, | Role of micronutrients in Alzheimer's disease: Review of available evidence |
- | Review, | AD, | NA |
4189- | Sesame, | Sesame oil mitigates memory impairment, oxidative stress, and neurodegeneration in a rat model of Alzheimer's disease. A pivotal role of NF-κB/p38MAPK/BDNF/PPAR-γ pathways |
- | in-vivo, | AD, | NA |
3663- | SFN, | Efficacy of Sulforaphane in Neurodegenerative Diseases |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3662- | SFN, | Sulforaphane Inhibits the Generation of Amyloid-β Oligomer and Promotes Spatial Learning and Memory in Alzheimer's Disease (PS1V97L) Transgenic Mice |
- | in-vivo, | AD, | NA |
3661- | SFN, | Beneficial Effects of Sulforaphane Treatment in Alzheimer's Disease May Be Mediated through Reduced HDAC1/3 and Increased P75NTR Expression |
- | in-vitro, | AD, | NA |
3658- | SFN, | Pre-Clinical Neuroprotective Evidences and Plausible Mechanisms of Sulforaphane in Alzheimer’s Disease |
- | Review, | AD, | NA |
1452- | SFN, | Sulforaphane Suppresses the Nicotine-Induced Expression of the Matrix Metalloproteinase-9 via Inhibiting ROS-Mediated AP-1 and NF-κB Signaling in Human Gastric Cancer Cells |
- | in-vitro, | GC, | AGS |
2168- | SFN, | Amelioration of Alzheimer's disease by neuroprotective effect of sulforaphane in animal model |
- | in-vivo, | AD, | NA |
3946- | Shank, | Phytochemical Profile, Pharmacological Attributes and Medicinal Properties of Convolvulus prostratus – A Cognitive Enhancer Herb for the Management of Neurodegenerative Etiologies |
- | Review, | AD, | NA |
3653- | SIL, | Silibinin ameliorates Aβ25-35-induced memory deficits in rats by modulating autophagy and attenuating neuroinflammation as well as oxidative stress |
- | in-vivo, | AD, | NA |
4207- | SIL, | Silymarin sex-dependently improves cognitive functions and alters TNF-α, BDNF, and glutamate in the hippocampus of mice with mild traumatic brain injury |
3321- | SIL, | cognitive_vitality_media/Silymarin-Cognitive-Vitality-For-Researchers.pdf">Silymarin (Milk thistle) |
- | Review, | AD, | NA |
3319- | SIL, | Silymarin and neurodegenerative diseases: Therapeutic potential and basic molecular mechanisms |
- | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
3318- | SIL, | Pharmaceutical prospects of Silymarin for the treatment of neurological patients: an updated insight |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3316- | SIL, | Chemo, | Silymarin Nanoparticles Counteract Cognitive Impairment Induced by Doxorubicin and Cyclophosphamide in Rats; Insights into Mitochondrial Dysfunction and Nrf2/HO-1 Axis |
4128- | Silicon, | Silicon as Versatile Player in Plant and Human Biology: Overlooked and Poorly Understood |
- | Review, | NA, | NA |
4122- | Silicon, | Silicon-rich mineral water as a non-invasive test of the 'aluminum hypothesis' in Alzheimer's disease |
- | Trial, | AD, | NA |
4123- | Silicon, | The potential influence of silica present in drinking water on Alzheimer's disease and associated disorders |
- | Review, | AD, | NA |
4134- | Silicon, | Garden Cress (Lepidium sativum) Seeds Ameliorated Aluminum-Induced Alzheimer Disease in Rats Through Antioxidant, Anti-Inflammatory, and Antiapoptotic Effects |
- | in-vivo, | AD, | NA |
4136- | Silicon, | Aluminum Should Now Be Considered a Primary Etiological Factor in Alzheimer’s Disease |
- | Review, | AD, | NA |
4129- | Silicon, | Silica and aluminum in drinking water and cognitive impairment in the elderly |
- | Study, | AD, | NA |
3050- | SK, | Systemic administration of Shikonin ameliorates cognitive impairment and neuron damage in NPSLE mice |
- | in-vivo, | Nor, | NA |
3049- | SK, | Shikonin Attenuates Chronic Cerebral Hypoperfusion-Induced Cognitive Impairment by Inhibiting Apoptosis via PTEN/Akt/CREB/BDNF Signaling |
- | in-vivo, | Nor, | NA | - | NA, | Stroke, | NA |
3958- | Taur, | Evaluation of the neuroprotective effect of taurine in Alzheimer’s disease using functional molecular imaging |
- | in-vivo, | AD, | NA |
3959- | Taur, | Taurine Directly Binds to Oligomeric Amyloid-β and Recovers Cognitive Deficits in Alzheimer Model Mice |
- | in-vivo, | AD, | NA |
3960- | Taur, | Versatile Triad Alliance: Bile Acid, Taurine and Microbiota |
- | Review, | AD, | NA | - | Review, | Stroke, | NA |
3961- | Taur, | Effects of Dietary Taurine Supplementation on Blood and Urine Taurine Concentrations in the Elderly Women with Dementia |
- | Human, | AD, | NA |
3962- | Taur, | The Development of Taurine Supplementary Menus for the Prevention of Dementia and Their Positive Effect on the Cognitive Function in the Elderly with Dementia |
- | Human, | AD, | NA |
4172- | TQ, | Chronic Administration of Thymoquinone Enhances Adult Hippocampal Neurogenesis and Improves Memory in Rats Via Regulating the BDNF Signaling Pathway |
- | in-vivo, | AD, | NA |
3570- | TQ, | Thymoquinone alleviates the experimentally induced Alzheimer's disease inflammation by modulation of TLRs signaling |
- | in-vivo, | AD, | NA |
3556- | TQ, | Thymoquinone alleviates the experimentally induced Alzheimer’s disease inflammation by modulation of TLRs signaling |
- | in-vivo, | AD, | NA |
3557- | TQ, | Thymoquinone protects against lipopolysaccharides-induced neurodegeneration and Alzheimer-like model in mice. |
- | in-vivo, | AD, | NA |
- | in-vivo, | AD, | NA |
3559- | TQ, | Molecular signaling pathway targeted therapeutic potential of thymoquinone in Alzheimer’s disease |
- | Review, | AD, | NA | - | Review, | Var, | NA |
3560- | TQ, | Protective effects of thymoquinone on D-galactose and aluminum chloride induced neurotoxicity in rats: biochemical, histological and behavioral changes |
- | in-vivo, | AD, | NA |
3563- | TQ, | Thymoquinone (TQ) demonstrates its neuroprotective effect via an anti-inflammatory action on the Aβ(1–42)-infused rat model of Alzheimer's disease |
- | in-vivo, | AD, | NA |
3564- | TQ, | The Potential Neuroprotective Effect of Thymoquinone on Scopolamine-Induced In Vivo Alzheimer's Disease-like Condition: Mechanistic Insights |
- | in-vivo, | AD, | NA |
3565- | TQ, | Thymoquinone as a potential therapeutic for Alzheimer’s disease in transgenic Drosophila melanogaster model |
3432- | TQ, | Thymoquinone: Review of Its Potential in the Treatment of Neurological Diseases |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3790- | UA, | Therapeutic applications of ursolic acid: a comprehensive review and utilization of predictive tools |
4313- | VitA,RetA, | Unraveling the molecular mechanisms of vitamin deficiency in Alzheimer's disease pathophysiology |
- | Review, | AD, | NA |
4314- | VitB1/Thiamine, | Unraveling the molecular mechanisms of vitamin deficiency in Alzheimer's disease pathophysiology |
- | Review, | AD, | NA |
4312- | VitB1/Thiamine, | Pharmacological thiamine levels as a therapeutic approach in Alzheimer's disease |
- | Review, | AD, | NA |
4311- | VitB1/Thiamine, | Benfotiamine treatment activates the Nrf2/ARE pathway and is neuroprotective in a transgenic mouse model of tauopathy |
- | in-vivo, | AD, | NA |
4049- | VitB1/Thiamine, | Vitamin B1 (thiamine) and dementia |
- | Review, | AD, | NA |
4056- | VitB12, | VitB6, | FA, | Vitamin B12, B6, or Folate and Cognitive Function in Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis |
- | Review, | AD, | NA |
4058- | VitB12, | VitB6, | FA, | The preventive efficacy of vitamin B supplements on the cognitive decline of elderly adults: a systematic review and meta-analysis |
- | Review, | AD, | NA |
4054- | VitB12, | VitB6, | FA, | Role of B vitamins in modulating homocysteine and metabolic pathways linked to brain atrophy: Metabolomics insights from the VITACOG trial |
- | Study, | AD, | NA |
4053- | VitB12, | VitB6, | FA, | Vitamins in Alzheimer’s Disease—Review of the Latest Reports |
- | Review, | AD, | NA |
4038- | VitB12, | Vitamin B12 and Age-Related Cognitive Decline—Dementia and “Alzheimer’s Disease” |
- | Review, | AD, | NA |
4067- | VitB12, | VitB6, | VitD3, | Plants, Plants, and More Plants: Plant-Derived Nutrients and Their Protective Roles in Cognitive Function, Alzheimer's Disease, and Other Dementias |
- | Review, | AD, | NA |
4047- | VitB12, | Cognitive impairment and vitamin B12: a review |
- | Review, | AD, | NA |
4046- | VitB12, | Plasma Vitamin B-12 Levels and Risk of Alzheimer’s Disease: A Case-Control Study |
- | Study, | AD, | NA |
4045- | VitB12, | FA, | Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial |
- | Trial, | AD, | NA |
4043- | VitB12, | FA, | Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment |
- | Trial, | AD, | NA |
4042- | VitB12, | Genetic determinants of low vitamin B12 levels in Alzheimer's disease risk |
- | Review, | AD, | NA |
4040- | VitB12, | FA, | Role of vitamin B12 and folic acid in treatment of Alzheimer’s disease: a meta-analysis of randomized control trials |
- | Review, | AD, | NA |
4041- | VitB12, | Thoughts on B-vitamins and dementia |
- | Review, | AD, | NA |
4318- | VitB12, | Unraveling the molecular mechanisms of vitamin deficiency in Alzheimer's disease pathophysiology |
- | Review, | AD, | NA |
- | in-vivo, | AD, | NA |
4033- | VitB3, | Can nicotinamide riboside protect against cognitive impairment? |
- | in-vivo, | AD, | NA |
4032- | VitB3, | Modulation of cGAS-STING Pathway by Nicotinamide Riboside in Alzheimer's Disease |
- | in-vivo, | AD, | NA |
4077- | VitB6, | FA, | VitB12, | VitD3, | VitE | Vitamin Supplementation as an Adjuvant Treatment for Alzheimer’s Disease |
- | Review, | AD, | NA |
4065- | VitB6, | VitB12, | FA, | Vitamin B6, B12, and Folic Acid Supplementation and Cognitive Function |
- | Review, | AD, | NA |
4052- | VitB6, | B-Vitamin Intake and Biomarker Status in Relation to Cognitive Decline in Healthy Older Adults in a 4-Year Follow-Up Study |
- | Study, | AD, | NA |
4062- | VitB6, | FA, | VitB12, | Vitamin B6, B9, and B12 Intakes and Cognitive Performance in Elders: National Health and Nutrition Examination Survey, 2011–2014 |
- | Study, | AD, | NA |
4055- | VitB6, | VitD3, | Vitamin B6 and vitamin D deficiency co-occurrence in geriatric memory patients |
- | Study, | AD, | NA |
4319- | VitC, | Unraveling the molecular mechanisms of vitamin deficiency in Alzheimer's disease pathophysiology |
- | Review, | AD, | NA |
3153- | VitC, | Vitamin C Status and Cognitive Function: A Systematic Review |
- | Review, | AD, | NA |
4320- | VitD3, | Unraveling the molecular mechanisms of vitamin deficiency in Alzheimer's disease pathophysiology |
- | Review, | AD, | NA |
4350- | VitD3, | Vitamin D: Evidence-Based Health Benefits and Recommendations for Population Guidelines |
- | Review, | Var, | NA | - | Review, | AD, | NA |
4184- | VitD3, | Neuroplasticity-related effects of vitamin D relevant to its neuroprotective effects: A narrative review |
- | Review, | NA, | NA |
4182- | VitD3, | The association between vitamin D and BDNF on cognition in older adults in Southern Brazil |
- | Study, | AD, | NA |
4086- | VitD3, | The beneficial role of vitamin D in Alzheimer's disease |
- | Review, | AD, | NA |
3921- | VitD3, | RES, | Vitamin D Combined with Resveratrol Prevents Cognitive Decline in SAMP8 Mice |
- | in-vivo, | AD, | NA |
4321- | VitE, | Unraveling the molecular mechanisms of vitamin deficiency in Alzheimer's disease pathophysiology |
- | Review, | AD, | NA |
4089- | VitE, | Cognitive function in elderly people is influenced by vitamin E status |
- | Study, | AD, | NA |
4088- | VitE, | Vitamin E and Alzheimer’s Disease—Is It Time for Personalized Medicine? |
- | Review, | AD, | NA |
4087- | VitE, | Vitamin E and Alzheimer's disease: what do we know so far? |
- | Review, | AD, | NA |
4079- | VitE, | VitC, | Effects of fruits and vegetables on levels of vitamins E and C in the brain and their association with cognitive performance |
- | Review, | AD, | NA |
4091- | VitK2, | The possible role of vitamin K deficiency in the pathogenesis of Alzheimer's disease and in augmenting brain damage associated with cardiovascular disease |
- | Review, | AD, | NA |
4090- | VitK2, | ProBio, | Vitamin K2 Holds Promise for Alzheimer's Prevention and Treatment |
- | Review, | AD, | NA |
4322- | VitK2, | Unraveling the molecular mechanisms of vitamin deficiency in Alzheimer's disease pathophysiology |
- | Review, | AD, | NA |
4309- | VitK2, | Vitamins in the Prevention and Support Therapy of Neurodegenerative Diseases |
- | Review, | NA, | NA |
4188- | VitK2, | Vitamin K2 protects against aluminium chloride-mediated neurodegeneration |
- | in-vivo, | NA, | NA |
4084- | Z, | Role of micronutrients in Alzheimer's disease: Review of available evidence |
- | Review, | AD, | NA |
4191- | Zeax, | Lut, | Effects of macular xanthophyll supplementation on brain-derived neurotrophic factor, pro-inflammatory cytokines, and cognitive performance |
- | Trial, | AD, | NA |
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:557 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid